Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?

Gragnano Felice; Calabro Paolo; Valgimigli Marco

首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?

【24h】

Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?

机译：是三重抗血栓形成，或者相当于其持续时间和组成，真正的罪魁祸首过量的心房颤动患者观察到冠状动脉介入的患者？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This commentary refers to 'Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials' by H.B. Golwala et al., 2018;39:1726-1735.

机译：该评论是指在经皮冠状动脉介入后心房颤动患者的“双抗血栓疗法的”安全性和有效性，其在经皮冠状动脉干预之后：通过H.B的随机临床试验进行系统审查和荟萃分析。 Golwala等人，2018年; 39：1726-1735。

著录项

来源
《European Heart Journal: The Journal of the European Society of Cardiology》 |2019年第2期|共2页
作者
Gragnano Felice; Calabro Paolo; Valgimigli Marco;
展开▼
作者单位

Univ Bern Dept Cardiol Univ Hosp Bern Freiburgstr 8 CH-3010 Bern Switzerland;

AORN St Anna &

San Sebastiano Div Clin Cardiol I-81100 F Palasciano Caserta Italy;

Univ Bern Dept Cardiol Univ Hosp Bern Freiburgstr 8 CH-3010 Bern Switzerland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention? [J] . Gragnano Felice, Calabro Paolo, Valgimigli Marco European Heart Journal: The Journal of the European Society of Cardiology . 2019,第2期

机译：是三重抗血栓形成，或者相当于其持续时间和组成，真正的罪魁祸首过量的心房颤动患者观察到冠状动脉介入的患者？
2. Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events? [J] . Kartik Gupta, Shane P. Prejean, Muthiah Vaduganathan, IJC Heart & Vasculature . 2019,第1期

机译：房颤患者经皮冠状动脉介入治疗后的双重抗栓治疗与三次抗栓治疗是否以增加缺血性事件风险为代价降低了出血风险？
3. Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention： a systematic review and meta-analysis of vitamin k antagonist a [J] . Phav Sophearith International Journal of Medicine . 2020,第1期

机译：在经皮冠状动脉介入的心房颤动或没有急性冠状动脉综合征的患者中双与抗血栓形成治疗的安全性和有效性：维生素K拮抗剂的系统审查和荟萃分析
4. Patients with Paroxysmal Atrial Fibrillation Undergoing "Ablate and Pace" Therapy: Is Prevention of Arrhythmic Recurrences Possible by Combined Overdrive and Biatrial Pacing? [C] . D. Igidbashian International Workshop on Cardiac Arrhythmias . 2002

机译：患有阵发性心房颤动的患者正在进行“烧蚀和速度”治疗：通过组合的过驱动和父母起搏预防心律失常复发？
5. Optimal Post-Procedural Therapy for Patients Ineligble for Treatment with Oral Anticoagulatiion Who Undergo Left Atrial Appendage Occlusion with the Watchman Device for Non-Valvular Atrial Fibrillation [D] . Whitehead, Kristen Marie. 2020

机译：用口腔抗凝血治疗患者患者的最佳过程治疗患者患有左心房阑尾闭塞与鹰刀用于非瓣膜心房颤动
6. Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk thromboembolic events and stent thrombosis [O] . Mila Menozzi, Andrea Rubboli, Antonio Manari, 2012

机译：房颤患者行冠状动脉支架置入术的三联抗血栓治疗：在出血风险血栓栓塞事件和支架血栓形成之间徘徊
7. Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis [O] . Menozzi Mila, Rubboli Andrea, Manari Antonio, 2012

机译：房颤患者行冠状动脉支架置入术的三联抗血栓治疗：徘徊在出血风险，血栓栓塞事件和支架血栓形成之间

Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?

摘要

著录项

相似文献

相关主题

期刊订阅